Ledger.Open graph →
SEC Form D · filed February 13, 2025

Latigo Biotherapeutics, Inc

Offering
$150.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
THOUSAND OAKS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Nima Farzan · San Francisco, CAExec · DirectorJim Tananbaum · San Francisco, CADirectorDeborah Palestrant · Boston, MADirectorKevin Raidy · Thousand Oaks, CADirectorTim Walbert · Thousand Oaks, CADirectorNancy Stagliano · GUILFORD, CTDirectorBeth Seidenberg · Palo Alto, CADirectorTim Lugo · Thousand Oaks, CAExecNancy Stagliano · GUILFORD, CTDirectorBeth Seidenberg · San Francisco, CADirectorNima Farzan · San Francisco, CAExec · DirectorJim Tananbaum · San Francisco, CADirectorDeborah Palestrant · Boston, MADirectorKevin Raidy · Thousand Oaks, CADirectorTim Lugo · Thousand Oaks, CAExecTim Walbert · Thousand Oaks, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗